Inspire Medical [INSP] vs Penumbra [PEN] Detailed Stock Comparison
Inspire Medical
NYSE
Loading...
Penumbra
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Inspire Medical wins in 8 metrics, Penumbra wins in 10 metrics, with 0 ties. Penumbra appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Inspire Medical | Penumbra | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 45.48 | 63.62 | Inspire Medical |
| Price-to-Book Ratio | 3.45 | 7.22 | Inspire Medical |
| Debt-to-Equity Ratio | 4.88 | 17.04 | Inspire Medical |
| PEG Ratio | 39.97 | 63.62 | Inspire Medical |
| EV/EBITDA | 39.72 | 43.56 | Inspire Medical |
| Profit Margin (TTM) | 6.17% | 11.54% | Penumbra |
| Operating Margin (TTM) | -1.53% | 21.87% | Penumbra |
| EBITDA Margin (TTM) | N/A | 21.87% | N/A |
| Return on Equity | 8.07% | 12.03% | Penumbra |
| Return on Assets (TTM) | 3.38% | 7.51% | Penumbra |
| Free Cash Flow (TTM) | $91.12M | $147.30M | Penumbra |
| 1-Year Return | -57.81% | 25.72% | Penumbra |
| Price-to-Sales Ratio (TTM) | 2.72 | 7.33 | Inspire Medical |
| Enterprise Value | $2.07B | $9.14B | Penumbra |
| EV/Revenue Ratio | 2.41 | 7.14 | Inspire Medical |
| Gross Profit Margin (TTM) | 84.03% | 65.99% | Inspire Medical |
| Revenue per Share (TTM) | $29 | $33 | Penumbra |
| Earnings per Share (Diluted) | $1.74 | $3.78 | Penumbra |
| Beta (Stock Volatility) | 1.22 | 0.40 | Penumbra |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Inspire Medical vs Penumbra Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Inspire Medical | 5.40% | -4.53% | -35.57% | -46.35% | -55.12% | -55.64% |
| Penumbra | 3.78% | 3.52% | 3.86% | -16.47% | -6.93% | 3.57% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Inspire Medical | -57.81% | -62.99% | -28.46% | 225.42% | 225.42% | 225.42% |
| Penumbra | 25.72% | 47.41% | 2.94% | 479.90% | 479.90% | 479.90% |
Performance & Financial Health Analysis: Inspire Medical vs Penumbra
| Metric | INSP | PEN |
|---|---|---|
| Market Information | ||
| Market Cap | $2.34B | $9.38B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 2,250,280 | 606,920 |
| 90 Day Avg. Volume | 1,156,100 | 478,647 |
| Last Close | $83.93 | $248.55 |
| 52 Week Range | $73.92 - $225.00 | $168.30 - $310.00 |
| % from 52W High | -62.70% | -19.82% |
| All-Time High | $330.00 (Jul 10, 2023) | $348.67 (Jun 26, 2023) |
| % from All-Time High | -74.57% | -28.71% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.13% |
| Quarterly Earnings Growth | N/A | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.12% |
| Operating Margin (TTM) | -0.02% | 0.22% |
| Return on Equity (TTM) | 0.08% | 0.12% |
| Debt to Equity (MRQ) | 4.88 | 17.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $22.92 | $33.32 |
| Cash per Share (MRQ) | $10.17 | $10.93 |
| Operating Cash Flow (TTM) | $117.45M | $36.77M |
| Levered Free Cash Flow (TTM) | $55.10M | $224.96M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Inspire Medical vs Penumbra
| Metric | INSP | PEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 45.48 | 63.62 |
| Forward P/E | 39.97 | 63.62 |
| PEG Ratio | 39.97 | 63.62 |
| Price to Sales (TTM) | 2.72 | 7.33 |
| Price to Book (MRQ) | 3.45 | 7.22 |
| Market Capitalization | ||
| Market Capitalization | $2.34B | $9.38B |
| Enterprise Value | $2.07B | $9.14B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.41 | 7.14 |
| Enterprise to EBITDA | 39.72 | 43.56 |
| Risk & Other Metrics | ||
| Beta | 1.22 | 0.40 |
| Book Value per Share (MRQ) | $22.92 | $33.32 |
Financial Statements Comparison: Inspire Medical vs Penumbra
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INSP | PEN |
|---|---|---|
| Revenue/Sales | $201.32M | $324.14M |
| Cost of Goods Sold | $30.71M | $108.26M |
| Gross Profit | $170.61M | $215.88M |
| Research & Development | $27.80M | $22.08M |
| Operating Income (EBIT) | $-1.49M | $40.35M |
| EBITDA | $1.56M | $49.20M |
| Pre-Tax Income | $4.16M | $43.86M |
| Income Tax | $1.17M | $4.64M |
| Net Income (Profit) | $2.99M | $39.22M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INSP | PEN |
|---|---|---|
| Cash & Equivalents | $53.88M | $376.05M |
| Total Current Assets | $571.68M | $999.71M |
| Total Current Liabilities | $63.47M | $158.63M |
| Long-Term Debt | $31.49M | $205.85M |
| Total Shareholders Equity | $635.74M | $1.21B |
| Retained Earnings | $-288.92M | $99.23M |
| Property, Plant & Equipment | $50.21M | $274.92M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INSP | PEN |
|---|---|---|
| Operating Cash Flow | $8.74M | $46.01M |
| Capital Expenditures | $-8.41M | $-13.47M |
| Free Cash Flow | $-15.11M | $35.50M |
| Debt Repayment | N/A | $-613,000 |
| Common Stock Repurchase | $-75.01M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INSP | PEN |
|---|---|---|
| Shares Short | 3.29M | 1.83M |
| Short Ratio | 5.52 | 4.26 |
| Short % of Float | 0.15% | 0.07% |
| Average Daily Volume (10 Day) | 2,250,280 | 606,920 |
| Average Daily Volume (90 Day) | 1,156,100 | 478,647 |
| Shares Outstanding | 29.74M | 38.49M |
| Float Shares | 29.10M | 37.66M |
| % Held by Insiders | 0.01% | 0.04% |
| % Held by Institutions | 1.19% | 0.92% |
Dividend Analysis & Yield Comparison: Inspire Medical vs Penumbra
| Metric | INSP | PEN |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |